Publication | Open Access

Efficacy of panobinostat and marizomib in acute myeloid leukemia and bortezomib-resistant models

Hematological MalignancyMedicineAcute Myeloid LeukemiaPharmacologyBortezomib-resistant ModelsMyeloid NeoplasiaPharmacotherapyAnti-cancer AgentOncologyCancer ResearchDrug DiscoveryDrug Resistance